Cas No.: | 2101626-26-8 |
SMILES: | C1C2=CC=C(OC(F)F)C=C2N=CC=1C(N[C@@H]1CC[C@@H](C(O)(C)C)CC1)=O |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | GSK-2894631A(HPGDS inhibitor 2) is a highly potent and selective hematopoietic prostaglandin D synthase (H-PGDS) inhibitor with an IC50 of 9.9 nM[1]. |
Target: | IC50: 9.9 nM (H-PGDS)[1] |
References: | [1]. Deaton DN, et al. The discovery of quinoline-3-carboxamides as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors. Bioorg Med Chem. 2019 Apr 15;27(8):1456-1478. |